The Alliance today is focused on a few key areas of quality measure advocacy: (1) Continued development of wound care-relevant QCDR measures, (2) Enabling clinicians across the wound care team to qualify for the newly incentivized Medicare payment system, and (3) Improving reimbursement through group reporting of quality measures. 

Continued development of wound care-relevant QCDR measures

Of primary concern is that the obligatory reporting of quality, resource use and clinical performance measures may not truly be indicative of our wound care work nor of the resources that we use to treat patients. We need outcome measures for advanced therapeutics like negative pressure and cellular products to ensure we can tie the cost of these interventions to the improved outcomes achieved with them.

Read More